Kovitz Investment Group Partners
HUMA icon

Kovitz Investment Group Partners’s Humacyte HUMA Stock Holding History

Kovitz Investment Group Partners’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,250
Closed -$34.8K – 667
2023
Q4 		$34.8K Buy
+12,250
New +$31.4K ﹤0.01% 410
2023
Q2 		– Sell
-11,250
Closed -$35K – 424
2023
Q1 		$35K Buy
+11,250
New +$32K ﹤0.01% 413
2022
Q3 		– Sell
-11,550
Closed -$37K – 405
2022
Q2 		$37K Hold
11,550
– – ﹤0.01% 402
2022
Q1 		$82K Buy
+11,550
New +$67.3K ﹤0.01% 411
2021
Q4 		– Sell
-11,050
Closed -$128K – 431
2021
Q3 		$128K Buy
+11,050
New +$126K ﹤0.01% 425

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Kovitz Investment Group Partners's HUMA Position: Q1 2024 in Review

Kovitz Investment Group Partners sold out of Humacyte (HUMA) in Q1 2024, closing a stake of 12,250 shares — an estimated $34.8K sold.

Kovitz Investment Group Partners first reported a position in HUMA in Q3 2021 and held it in 5 quarters. The position peaked at $128K in Q3 2021. 96 funds tracked by Wall St. Rank hold HUMA as of Q1 2024.

  • Kovitz Investment Group Partners reported no remaining Humacyte position as of Q1 2024 after selling out during the quarter.
  • Kovitz Investment Group Partners sold 12,250 Humacyte shares in Q1 2024, an estimated $34.8K.
  • Kovitz Investment Group Partners first reported a position in Humacyte in Q3 2021 and held it in 5 quarters.
  • Kovitz Investment Group Partners's Humacyte position peaked at $128K in Q3 2021.
  • 96 funds tracked by Wall St. Rank held Humacyte as of Q1 2024.

Based on Kovitz Investment Group Partners's 13F filing for Q1 2024, filed 14 May 2024.